Universal Beteiligungs und Servicegesellschaft mbH Decreases Stock Position in Teleflex Incorporated (NYSE:TFX)

Universal Beteiligungs und Servicegesellschaft mbH lowered its position in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 69.7% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 11,118 shares of the medical technology company's stock after selling 25,561 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH's holdings in Teleflex were worth $1,536,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. Y Intercept Hong Kong Ltd increased its stake in Teleflex by 1,643.6% during the 1st quarter. Y Intercept Hong Kong Ltd now owns 43,503 shares of the medical technology company's stock worth $6,012,000 after buying an additional 41,008 shares during the period. Teachers Retirement System of The State of Kentucky grew its stake in shares of Teleflex by 437.8% during the first quarter. Teachers Retirement System of The State of Kentucky now owns 18,883 shares of the medical technology company's stock valued at $2,609,000 after acquiring an additional 15,372 shares in the last quarter. South Dakota Investment Council increased its position in shares of Teleflex by 11.9% during the first quarter. South Dakota Investment Council now owns 10,330 shares of the medical technology company's stock worth $1,428,000 after acquiring an additional 1,100 shares during the last quarter. Calton & Associates Inc. acquired a new position in shares of Teleflex in the first quarter worth about $132,000. Finally, Verdence Capital Advisors LLC boosted its holdings in Teleflex by 58.6% in the first quarter. Verdence Capital Advisors LLC now owns 3,061 shares of the medical technology company's stock valued at $423,000 after purchasing an additional 1,131 shares during the last quarter. 95.62% of the stock is owned by institutional investors and hedge funds.

Teleflex Price Performance

TFX opened at $119.54 on Friday. The company has a quick ratio of 1.32, a current ratio of 2.28 and a debt-to-equity ratio of 0.44. The company's 50-day moving average price is $118.83 and its 200 day moving average price is $137.60. Teleflex Incorporated has a fifty-two week low of $108.90 and a fifty-two week high of $249.90. The firm has a market cap of $5.28 billion, a price-to-earnings ratio of 37.71, a price-to-earnings-growth ratio of 1.78 and a beta of 1.08.

Teleflex (NYSE:TFX - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The medical technology company reported $3.73 earnings per share for the quarter, topping analysts' consensus estimates of $3.36 by $0.37. The business had revenue of $780.90 million for the quarter, compared to analysts' expectations of $771.53 million. Teleflex had a return on equity of 14.73% and a net margin of 4.96%. The business's quarterly revenue was up 4.2% on a year-over-year basis. During the same period in the prior year, the firm earned $3.42 EPS. As a group, sell-side analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, September 15th. Stockholders of record on Friday, August 15th will be given a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 1.1%. Teleflex's dividend payout ratio is currently 42.90%.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on TFX shares. Truist Financial dropped their price objective on Teleflex from $140.00 to $137.00 and set a "hold" rating on the stock in a report on Monday, May 5th. Wall Street Zen lowered shares of Teleflex from a "buy" rating to a "hold" rating in a research note on Sunday, June 29th. Royal Bank Of Canada set a $130.00 price target on shares of Teleflex and gave the company a "sector perform" rating in a report on Tuesday, July 15th. Morgan Stanley decreased their price objective on shares of Teleflex from $191.00 to $173.00 and set an "overweight" rating for the company in a report on Monday, May 5th. Finally, Wells Fargo & Company cut their target price on shares of Teleflex from $146.00 to $137.00 and set an "equal weight" rating on the stock in a research note on Friday, May 2nd. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Hold" and an average target price of $159.63.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.